Alerts will be sent to your verified email
Verify Email
EIKO
|
Eiko Lifesciences
|
Sunil Healthcare
|
Daikaffil Chemicals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-16.62 % | 1.91 % | 6.39 % |
|
5yr average Equity Multiplier
|
2.12 | 2.47 | 1.55 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.77 | 1.0 |
|
5yr Avg Net Profit Margin
|
-3.7 % | 0.33 % | 2.14 % |
|
Price to Book
|
1.22 | 1.09 | 8.25 |
|
P/E
|
25.86 | 397.37 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
61.48 Days | 113.61 Days | 230.16 Days |
|
Inventory Days
|
214.38 Days | 64.09 Days | 60.47 Days |
|
Days Receivable
|
57.98 Days | 139.61 Days | 295.02 Days |
|
Days Payable
|
248.22 Days | 139.86 Days | 76.92 Days |
|
5yr Average Interest Coverage Ratio
|
-0.09 | 1.69 | -13.02 |
|
5yr Avg ROCE
|
-109.51 % | 9.44 % | 10.97 % |
|
5yr Avg Operating Profit Margin
|
-9.68 % | 5.47 % | 5.52 % |
|
5 yr average Debt to Equity
|
0.3 | 0.9 | 0.05 |
|
5yr CAGR Net Profit
|
60.2 % | -18.44 % | n/a |
|
5yr Average Return on Assets
|
-4.56 % | 1.18 % | 4.25 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
37.17 % | 73.53 % | 52.65 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
22.49 % | 0.0 | 21.46 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Eiko Lifesciences
|
Sunil Healthcare
|
Daikaffil Chemicals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|